4th Targeted Radiopharmaceuticals Europe

Kongressthemen
Success of prostate cancer treatments has triggered a seismic shift in the status of the TRP field over the last year and sparked more research investment than ever before.

The Targeted Radiopharmaceuticals Summit Europe returns for its fourth year as the only event to address the needs of drug developers at all development stages, from both medical and operational perspectives.

Kongressorganizer (PCO)
Hanson Wade

https://go.evvnt.com/1314898-2?pid=4832

Frau Rhianna Price